Dr. Rajkumar Halder, CEO and Founder of Ruhvenile Biomedical having 18+ years research experience including 10 years aboard. He has more than 14+ years of extensive basic and translational research experiences from leading research institutes/university around the globe.

Rajkumar is currently focusing on to control cell fate using small organic molecules and natural products to prevent and/or cure metabolic disorder (Cancer, Diabetes, and Obesity) and infectious diseases. He also focuses on to prolong the healthy living through establishing and using the cocktail of natural products.

Professional Experience

Has more than 14+ years of extensive basic and translational research experiences from leading research institutes/university around the globe. Rajkumar is currently focusing on to control cell fate using small organic molecules and natural products to prevent and/or cure metabolic disorder (Cancer, Diabetes, and Obesity) and infectious diseases

Industry Experience

Two and half years of Pharmaceutical Industry Experiences at Novartis (GNF), San Diego, CA, USA on drug discovery for resistant and persistent mycobacterium Tuberculosis. His research work resulted in few clinical and preclinical compounds for different diseases.

Research Expertise

Completed his Ph. D. in Organic Chemistry from University of the Basque Country, Spain after finishing his study from Indian Institute of Technology-Kharagpur, India. He did his postdoctoral research from The Scripps Research Institute, Department of Chemistry and the Skaggs Institute for Chemical Biology, La Jolla, California and Max-Planck-Institute for Coal Research, Muelheim an der Ruhr, Germany.